The work, inspired by an investigation into a genetic form of the condition, has the potential to
affect therapeutic research for millions of people suffering from progressive kidney diseases.
For decades, the Tourette Association of America has led the way in
research and
therapeutic development for Tourette Syndrome and other Tic Disorders, and has provided more than $ 20 million in grants to fund
research and develop medical programs that meet the needs of those
affected by Tourette.
A 2016 study by researchers from the Buck Institute for
Research on Ageing and the UCLA Easton Laboratories for Neurodegenerative Disease
Research, showed that memory loss in Alzheimer's patients can be reversed, and improvement sustained, using a complex, 36 - point
therapeutic personalized program that involves comprehensive changes in diet, brain stimulation, exercise, optimization of sleep, specific pharmaceuticals and vitamins, and multiple additional steps that
affect brain chemistry.